Zhitong Finance App News, Zhaoke Ophthalmology-B (06622.HK) announced that on June 22, 2026, the company has acquired the global rights to NVK002 (atropine sulphate eye drops). NVK002 is a product designed to slow the deepening of myopia in children.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.